Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials

Adriaan A. Voors*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)257-259
Number of pages3
JournalJACC. Heart failure
Volume6
Issue number3
DOIs
Publication statusPublished - Mar-2018

Keywords

  • eligibility
  • heart failure
  • N-terminal pro-B-type natriuretic peptide
  • registry
  • trials
  • PRESERVED EJECTION FRACTION
  • HEART-FAILURE
  • NATRIURETIC PEPTIDE

Cite this